Diclofenac vs Dexamethasone in Combined Surgery

Evaluation the Effect of Diclofenac Drops vs Dexamethasone Drops in Trabeculectomy and Cataract Surgery

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00825864

Enrollment

Registered

2009-01-21

Start date

2004-01-31

Completion date

2008-01-31

Last updated

2009-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, Glaucoma

Brief summary

To study the effect of Diclofenac drops or Dexamethasone drops on combined surgery of trabeculectomy and cataract surgery.

Interventions

DRUGdiclofenac drops

one drop 4 times a day for 3 months

DRUGdexamethasone sodium phosphate 0.1% eye drops

for first week after the operation : one drop 6 times a day. Then tapering by reducing one drop for a week

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

40 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients scheduled for combines surgery of trabeculectomy and cataract surgery

Exclusion criteria

* severe complicated surgery like vitreal loss, expulsive hemorrhage, endophthalmitis

Design outcomes

Primary

Measure	Time frame
intraocular pressure	year

Secondary

Measure	Time frame
the number of antiglaucoma medications	year

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026